HRT & Menopause
In the US, at least 40 million women are currently experiencing menopause, and an additional 20 million women will reach menopause during the next decade. Treatment of menopause includes hormone replacement therapy (HRT), which is a topic that has gained national and international prominence in recent years. Today, Bioidentical HRT (BHRT) is rapidly becoming more widely used and has been in the press extensively.
As published in the following article from RXTriad – Vol.15 | No.3
- Read the entire article about bioidentical HRT and menopause.
- http://www.huffingtonpost.com/mache-seibel-md/glaucoma_b_1835008.html”>Low Estrogen Linked to Glaucoma
A Comparative Review of Conventional and Bioidentical Hormone Replacement Therapy
Proponents for bioidentical hormones claim that they are safer than comparable synthetic and nonhuman versions of HRT.
Bioidentical hormones have a chemical structure identical to human hormones but are chemically synthesized, such as progesterone, estriol, and estradiol. Nonbioidentical hormones are not structurally identical to human hormones and may either be chemically synthesized, such as MPA, or derived from a nonhuman source, such as CEE.
- Read the entire article, the Bioidentical Hormone Debate: are Bioidentical Hormones (estradiol, estriol, and Progesterone) safer or More efficacious than Commonly used synthetic Versions in Hormone replacement therapy?
© Postgraduate Medicine, Volume 121, issue 1, January 2009, issn – 0032-5481, e-issn – 1941-9260
Bioidentical Hormone Replacement Therapy and Cardiovascular & Breast Health
Read this review of how conventional and bioidential hormone replacement affects cardiovascular & breast health.